Qingdi Q Li

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Perfusion of a cerebral protective solution enhances neuroprotection in a rabbit model of occlusion-reperfusion: prolonged cerebral dormancy time
    LiBin Ye
    Department of Medicine, Rui Kang Hospital, Guangxi University of Chinese Medicine, Nanning, P R China
    In Vivo 28:727-32. 2014
  2. pmc β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK
    Quentin Q Li
    National Institutes of Health, Bethesda, MD 20892, USA
    Int J Oncol 43:721-8. 2013
  3. ncbi request reprint A novel approach for enriching cancer stem cells from the human SW-13 adrenocortical carcinoma cell line
    Wenqing Zeng
    National Institutes of Health, Bethesda, MD 20892, U S A E mail or Dr Zuojie Luo, Department of Endocrinology, First Hospital of Guangxi Medical University, Nanning 530021, China
    Anticancer Res 34:117-23. 2014
  4. ncbi request reprint β-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas
    Q Quentin Li
    Beihai Institute of Endocrine and Metabolic Diseases, Beihai, Guangxi, PR China
    Anticancer Res 33:1421-8. 2013
  5. ncbi request reprint β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells
    Baobo Zou
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Anticancer Res 33:929-40. 2013
  6. doi request reprint Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs
    Q Quentin Li
    West Virginia University School of Medicine, Morgantown, WV 26506, USA
    Med Oncol 30:488. 2013
  7. pmc Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells
    Qingdi Quentin Li
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Anticancer Res 33:65-76. 2013
  8. pmc β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells
    Rebecca X Lee
    Department of Microbiology, Immunology and Cell Biology, Mary Babb Randolph Cancer Center, West Virginia University School of Medicine, Morgantown, WV, USA
    Anticancer Res 32:3103-13. 2012
  9. ncbi request reprint beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis
    Qingdi Q Li
    The Mary Babb Randolph Cancer Center and Department of Microbiology, Immunology and Cell Biology, Robert C Byrd Health Sciences Center, West Virginia University of Medicine, Morgantown, WV 26506, USA
    Oncol Rep 22:161-70. 2009
  10. ncbi request reprint In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma
    Jinshun Zhao
    Mary Babb Randolph Cancer Center, Department of Microbiology, Immunology and Cell Biology, West Virginia University, Morgantown, WV 26506, USA
    Int J Oncol 31:241-52. 2007

Collaborators

  • Eddie Reed
  • Jinshun Zhao
  • Li Li
  • Wei Zhang
  • Hong Ding
  • Kevin Gardner
  • Lan Huang
  • Tingting Lu
  • Honglin Song
  • Yan Ma
  • Yunfeng Zhu
  • Manchao Zhang
  • Gangduo Wang
  • LiBin Ye
  • Wenqing Zeng
  • Baobo Zou
  • Rebecca X Lee
  • Qiang Xiao
  • Ning Xia
  • Bujian Tang
  • Xiaosong Zhong
  • Decheng Lu
  • Xinghuan Liang
  • Jia Zhou
  • Meilin Ye
  • Fengping Wu
  • Zuojie Luo
  • Zhaolin Zhang
  • Michael Weintraub
  • Zhenxing Huang
  • Xiaocong Kuang
  • Yingfen Qin
  • Aiyuan Hua
  • Yuan Qin
  • Lili Wu
  • Xiaozhou Chen
  • Bo Dai
  • Jueli M Li
  • Christopher F Cuff
  • Ning Tan
  • Yubo Xie
  • Keyi Xia
  • Changqing Wang
  • Junyi Xu
  • Changqing Xiao
  • Hongming Deng
  • Naizun Wang
  • Hanlei Shen
  • Suxian Zhou
  • Yuzhen Liang
  • Hailin Pan
  • Zhifeng Jiang
  • Danrong Li
  • Yingzi Luan
  • Xiping Li
  • Guodong Hu
  • Cheryl Neace

Detail Information

Publications21

  1. ncbi request reprint Perfusion of a cerebral protective solution enhances neuroprotection in a rabbit model of occlusion-reperfusion: prolonged cerebral dormancy time
    LiBin Ye
    Department of Medicine, Rui Kang Hospital, Guangxi University of Chinese Medicine, Nanning, P R China
    In Vivo 28:727-32. 2014
    ....
  2. pmc β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK
    Quentin Q Li
    National Institutes of Health, Bethesda, MD 20892, USA
    Int J Oncol 43:721-8. 2013
    ....
  3. ncbi request reprint A novel approach for enriching cancer stem cells from the human SW-13 adrenocortical carcinoma cell line
    Wenqing Zeng
    National Institutes of Health, Bethesda, MD 20892, U S A E mail or Dr Zuojie Luo, Department of Endocrinology, First Hospital of Guangxi Medical University, Nanning 530021, China
    Anticancer Res 34:117-23. 2014
    ..In this method, the administration of cyclophosphamide selectively kills cancer cells without toxicity to CSCs and thereby provides a practical approach for achieving the enrichment of CSCs in ACC. ..
  4. ncbi request reprint β-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas
    Q Quentin Li
    Beihai Institute of Endocrine and Metabolic Diseases, Beihai, Guangxi, PR China
    Anticancer Res 33:1421-8. 2013
    ..Cisplatin combined with β-elemene as a chemosensitizer warrants further pre-clinical therapeutic studies and may be useful for the treatment of cisplatin-resistant bladder cancer and other types of carcinomas...
  5. ncbi request reprint β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells
    Baobo Zou
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Anticancer Res 33:929-40. 2013
    ..This promising new therapeutic combination warrants further pre-clinical exploration for the treatment of chemoresistant ovarian cancer and other types of tumors...
  6. doi request reprint Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs
    Q Quentin Li
    West Virginia University School of Medicine, Morgantown, WV 26506, USA
    Med Oncol 30:488. 2013
    ....
  7. pmc Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells
    Qingdi Quentin Li
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Anticancer Res 33:65-76. 2013
    ..Overall, this study provides, to our knowledge, the first evidence showing that synthetic analogs of β-elemene hold promise for patients with brain tumors...
  8. pmc β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells
    Rebecca X Lee
    Department of Microbiology, Immunology and Cell Biology, Mary Babb Randolph Cancer Center, West Virginia University School of Medicine, Morgantown, WV, USA
    Anticancer Res 32:3103-13. 2012
    ....
  9. ncbi request reprint beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis
    Qingdi Q Li
    The Mary Babb Randolph Cancer Center and Department of Microbiology, Immunology and Cell Biology, Robert C Byrd Health Sciences Center, West Virginia University of Medicine, Morgantown, WV 26506, USA
    Oncol Rep 22:161-70. 2009
    ..Our data provide a rationale for developing a combination of beta-elemene and cisplatin as a regimen for the treatment of lung carcinoma and other cisplatin-resistant tumors...
  10. ncbi request reprint In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma
    Jinshun Zhao
    Mary Babb Randolph Cancer Center, Department of Microbiology, Immunology and Cell Biology, West Virginia University, Morgantown, WV 26506, USA
    Int J Oncol 31:241-52. 2007
    ..Finally, the beta-elemene-induced alteration of cell membrane permeability, which has potential to result in enhanced cellular uptake of taxanes, may also contribute to the synergistic interactions of the combination treatments...
  11. ncbi request reprint Demonstration of differential gene expression between sensitive and resistant ovarian tumor cells by fluorescence differential display-PCR analysis
    Li Li
    Department of Gynecologic Oncology, Cancer Institute and Hospital, Guangxi Medical University Medical Center, Nanning, Guangxi 530021, P R China
    Oncol Rep 13:793-9. 2005
    ....
  12. ncbi request reprint Development and characterization of five cell models for chemoresistance studies of human ovarian carcinoma
    Li Li
    Department of Gynecologic Oncology, Medical University of Guangxi Cancer Institute and Hospital, Nanning 530021, P R China
    Int J Mol Med 14:257-64. 2004
    ..Taken together, our findings indicate that these models may be potentially used to assess the biochemical and genetic mechanisms of drug resistance in human ovarian cancer and to identify new drug resistance-related genes...
  13. ncbi request reprint Characterization of the mechanisms of electrochemotherapy in an in vitro model for human cervical cancer
    Bujian Tang
    Guangxi Medical University Cancer Hospital, Nanning 530021, P R China
    Int J Oncol 26:703-11. 2005
    ....
  14. ncbi request reprint Molecular mechanism of antitumor activity of taxanes in lung cancer (Review)
    Jinshun Zhao
    The Mary Babb Randolph Cancer Center, and Department of Microbiology, Immunology and Cell Biology, West Virginia University Health Sciences Center, Morgantown, 26506, USA
    Int J Oncol 27:247-56. 2005
    ....
  15. ncbi request reprint Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells
    Xiaosong Zhong
    Mary Babb Randolph Cancer Center, and Department of Microbiology, Immunology and Cell Biology, West Virginia University School of Medicine and Robert C Byrd Health Sciences Center, Morgantown, WV 26506, USA
    Int J Oncol 25:445-51. 2004
    ..Together, these results suggest that the chemosensitizing effect of SU5416 on ovarian tumor cells may be mediated, at least in part, through inhibiting G1 checkpoint control and up-regulating the apoptotic response to cisplatin...
  16. ncbi request reprint Transcription factor E2F-1 is upregulated in human gastric cancer tissues and its overexpression suppresses gastric tumor cell proliferation
    Qiang Xiao
    Department of Surgery, First Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P R China
    Cell Oncol 29:335-49. 2007
    ....
  17. ncbi request reprint Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)
    Gangduo Wang
    Mary Babb Randolph Cancer Center and Department of Microbiology, Immunology and Cell Biology, West Virginia University Health Sciences Center, Morgantown, WV 26506, USA
    Oncol Rep 12:955-65. 2004
    ....
  18. ncbi request reprint Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer
    Li Li
    Department of Gynecologic Oncology, Guangxi Medical University Cancer Institute and Hospital, Nanning 530021, China
    Anticancer Res 24:1973-9. 2004
    ....
  19. ncbi request reprint Apoptosis in prostate cancer: progressive and therapeutic implications (Review)
    Gangduo Wang
    Mary Babb Randolph Cancer Center, West Virginia University Health Sciences Center, Morgantown, WV 26506, USA
    Int J Mol Med 14:23-34. 2004
    ....
  20. ncbi request reprint CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy
    Ning Xia
    Department of Endocrinology, First Hospital of Guangxi Medical University, Nanning 530021, PR China
    Int J Mol Med 17:911-6. 2006
    ....
  21. ncbi request reprint Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis
    Wei Zhang
    Department of Gynecologic Oncology, Cancer Hospital, Guangxi Medical University, Nanning, Guangxi 530021, P R China
    Anticancer Res 31:3423-8. 2011
    ..This study evaluated the clinical value of the combined detection of serum cathepsin L (CL), heparanase (Hpa), and matrix metalloproteinase-9 (MMP-9) for determining the degree of ovarian cancer invasion and metastasis before surgery...